208 related articles for article (PubMed ID: 16400523)
1. Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events.
Werdich XQ; Penn JS
Angiogenesis; 2005; 8(4):315-26. PubMed ID: 16400523
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
4. Differential effects on cell motility, embryonic stem cell self-renewal and senescence by diverse Src kinase family inhibitors.
Tamm C; Galitó SP; Annerén C
Exp Cell Res; 2012 Feb; 318(4):336-49. PubMed ID: 22197704
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity.
Galvagni F; Pennacchini S; Salameh A; Rocchigiani M; Neri F; Orlandini M; Petraglia F; Gotta S; Sardone GL; Matteucci G; Terstappen GC; Oliviero S
Circ Res; 2010 Jun; 106(12):1839-48. PubMed ID: 20431062
[TBL] [Abstract][Full Text] [Related]
6. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation.
Mukhopadhyay D; Tsiokas L; Zhou XM; Foster D; Brugge JS; Sukhatme VP
Nature; 1995 Jun; 375(6532):577-81. PubMed ID: 7540725
[TBL] [Abstract][Full Text] [Related]
8. Src family kinases are required for integrin but not PDGFR signal transduction.
Klinghoffer RA; Sachsenmaier C; Cooper JA; Soriano P
EMBO J; 1999 May; 18(9):2459-71. PubMed ID: 10228160
[TBL] [Abstract][Full Text] [Related]
9. Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain.
Sato I; Obata Y; Kasahara K; Nakayama Y; Fukumoto Y; Yamasaki T; Yokoyama KK; Saito T; Yamaguchi N
J Cell Sci; 2009 Apr; 122(Pt 7):965-75. PubMed ID: 19258394
[TBL] [Abstract][Full Text] [Related]
10. Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES.
Zhang P; Greendorfer JS; Jiao J; Kelpke SC; Thompson JA
Arch Biochem Biophys; 2006 Jun; 450(1):50-62. PubMed ID: 16631103
[TBL] [Abstract][Full Text] [Related]
11. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.
Brickell PM
Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720
[TBL] [Abstract][Full Text] [Related]
12. The membrane targeting and spatial activation of Src, Yes and Fyn is influenced by palmitoylation and distinct RhoB/RhoD endosome requirements.
Sandilands E; Brunton VG; Frame MC
J Cell Sci; 2007 Aug; 120(Pt 15):2555-64. PubMed ID: 17623777
[TBL] [Abstract][Full Text] [Related]
13. Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells.
Berman-Golan D; Elson A
Oncogene; 2007 Oct; 26(49):7028-37. PubMed ID: 17486066
[TBL] [Abstract][Full Text] [Related]
14. Yes is a central mediator of cell growth in malignant mesothelioma cells.
Sato A; Sekine M; Virgona N; Ota M; Yano T
Oncol Rep; 2012 Nov; 28(5):1889-93. PubMed ID: 22948717
[TBL] [Abstract][Full Text] [Related]
15. Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.
Szalmás A; Gyöngyösi E; Ferenczi A; László B; Karosi T; Csomor P; Gergely L; Veress G; Kónya J
Virol J; 2013 Mar; 10():79. PubMed ID: 23497302
[TBL] [Abstract][Full Text] [Related]
16. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
17. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability.
Eliceiri BP; Paul R; Schwartzberg PL; Hood JD; Leng J; Cheresh DA
Mol Cell; 1999 Dec; 4(6):915-24. PubMed ID: 10635317
[TBL] [Abstract][Full Text] [Related]
18. Cyclic stretch induces reorientation of cells in a Src family kinase- and p130Cas-dependent manner.
Niediek V; Born S; Hampe N; Kirchgessner N; Merkel R; Hoffmann B
Eur J Cell Biol; 2012 Feb; 91(2):118-28. PubMed ID: 22178114
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn.
Kanda S; Mochizuki Y; Nakamura T; Miyata Y; Matsuyama T; Kanetake H
J Cell Sci; 2005 Mar; 118(Pt 5):961-70. PubMed ID: 15713745
[TBL] [Abstract][Full Text] [Related]
20. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]